Tuesday, October 20, 2020
Home Tags Response

Tag: Response

Kyowa Kirin Presents New Data on Response to Treatment in Cutaneous...

GALASHIELS, Scotland--(BUSINESS WIRE)--Kyowa Kirin International PLC (Kyowa Kirin), a wholly owned subsidiary of Kyowa Kirin Co.,...

Increasing effectiveness of sexual violence response at UNM: UNM Newsroom

The UNM Action Collaborative for Preventing Sexual Harassment in Higher Education, a local facet of the National Academies for Science,...

STELARA® (ustekinumab) Five-Year Results Presented from Long-term Extension Study of Clinical...

SPRING HOUSE, Pa., Oct. 12, 2020 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new, final five-year data from the Phase...

Key Figure In County’s COVID Response To Leave Health Department

One of the leaders of McLean County’s COVID-19 response is leaving her job at the end of month. Melissa Graven is the communicable...

CAR T cell therapy can predict treatment response in patients with...

Reviewed by Emily Henderson, B.Sc.Oct 6 2020 Researchers at The University of Texas...

Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient...

This article was originally published here Prostate Cancer Prostatic Dis. 2020 Oct 2. doi: 10.1038/s41391-020-00295-z. Online ahead of print. ABSTRACT BACKGROUND: Precision medicine approaches for managing patients...

55 % Overall Response Rate on the safety extension cohorts of...

GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier Growth Market: ISOFOL), today provided an update on the...

Medicare Issues Draft Local Coverage Determination for Signatera™ in Immunotherapy Response...

  SAN CARLOS, Calif., Sept. 24, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the CMS Molecular...

Medicare Issues Draft Local Coverage Determination for Signatera™ in Immunotherapy Response...

SAN CARLOS, Calif., Sept. 24, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the CMS Molecular...
20,764FansLike
2,387FollowersFollow
16,600SubscribersSubscribe

EDITOR PICKS